Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study
Conclusions:
Subcutaneous regular insulin may be the short-acting insulin preparation of choice for this subset of diabetic patients. Clinical trial is required before a definitive recommendation can be made.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: Stull, M. C., Strilka, R. J., Clemens, M. S., Armen, S. B. Tags: Original Articles Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Humalog | Insulin | Nutrition | Science | Study